(Q39311553)

10 September 2017

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death (English)

1 reference

10 September 2017

1 reference

19

Laurence Zitvogel

0 references

Guido Kroemer

21

Guido Kroemer

0 references

Lorenzo Galluzzi

17

Lorenzo Galluzzi

0 references

François Ghiringhelli

15

François Ghiringhelli

0 references

Mickaël Michaud

9

Mickaël Michaud

0 references

Clara Locher

13

Clara Locher

0 references

Erika Vacchelli

2

Erika Vacchelli

0 references

Isabelle Martins

4

Isabelle Martins

0 references

Grégoire Mignot

10

Grégoire Mignot

0 references

Yuting Ma

5

Yuting Ma

1 reference

10 September 2017

7

Takahiro Yamazaki

1 reference

10 September 2017

18

Fabrice André

0 references

Sandy Adjemian

3

Sandy Adjemian

1 reference

10 September 2017

20

Oliver Kepp

0 references

Laurie Menger

Laurie Menger

1

0 references

Shensi Shen

Shensi Shen

6

0 references

Abdul Qader Sukkurwala

8

Abdul Qader Sukkurwala

1 reference

10 September 2017

11

Frederic Schlemmer

1 reference

10 September 2017

16

Nazanine Modjtahedi

1 reference

10 September 2017

Eric Sulpice

12

1 reference

PubMed ID

22814852

10 September 2017

Xavier Gidrol

14

1 reference

PubMed ID

22814852

10 September 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

Science Translational Medicine

10 September 2017

1 reference

10 September 2017

4

1 reference

10 September 2017

143

1 reference

10 September 2017

143ra99

1 reference

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

10 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Immune parameters affecting the efficacy of chemotherapeutic regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Cancer immunotherapy--revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Human tumor cells killed by anthracyclines induce a tumor-specific immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Immunogenic death of colon cancer cells treated with oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Armed response: how dying cells influence T-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Visualization of ATP release in pancreatic acini in response to cholinergic stimulus. Use of fluorescent probes and confocal microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Classification of chemotherapeutic agents based on their differential in vitro effects on dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Digitalis. Mechanisms of action and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Cardiac glycosides are potent inhibitors of interferon-β gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Cardiac glycosides as novel cancer therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Novel therapeutic applications of cardiac glycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Digoxin use and the risk of breast cancer in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

Calcium and cell death mechanisms: a perspective from the cell death community

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3003807

10.1126/SCITRANSLMED.3003807

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference

PubMed ID

22814852